 Matthew Bell
Concepts (121)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Choice Behavior | 9 | 2020 | 81 | 3.080 |
Why?
| | Reinforcement Schedule | 12 | 2021 | 71 | 2.700 |
Why?
| | Conditioning, Operant | 9 | 2021 | 104 | 2.140 |
Why?
| | Extinction, Psychological | 7 | 2021 | 34 | 1.980 |
Why?
| | Columbidae | 14 | 2021 | 53 | 1.790 |
Why?
| | Association Learning | 6 | 2016 | 11 | 0.870 |
Why?
| | Memory, Long-Term | 2 | 2014 | 4 | 0.850 |
Why?
| | Reaction Time | 4 | 2017 | 207 | 0.750 |
Why?
| | Behavior, Animal | 3 | 2007 | 185 | 0.730 |
Why?
| | Mental Recall | 3 | 2023 | 60 | 0.650 |
Why?
| | Asthma | 2 | 2015 | 316 | 0.650 |
Why?
| | Animals | 17 | 2021 | 13464 | 0.530 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2017 | 146 | 0.520 |
Why?
| | Food | 1 | 2016 | 66 | 0.500 |
Why?
| | Antibodies, Anti-Idiotypic | 2 | 2013 | 25 | 0.480 |
Why?
| | Anaphylaxis | 2 | 2015 | 69 | 0.480 |
Why?
| | Memory | 3 | 2016 | 97 | 0.470 |
Why?
| | Motivation | 3 | 2007 | 282 | 0.450 |
Why?
| | Generalization, Response | 1 | 2013 | 3 | 0.420 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2013 | 235 | 0.420 |
Why?
| | Time Factors | 8 | 2020 | 2997 | 0.410 |
Why?
| | Methicillin | 1 | 2012 | 10 | 0.380 |
Why?
| | Clindamycin | 1 | 2012 | 14 | 0.380 |
Why?
| | Mastocytosis, Systemic | 1 | 2012 | 6 | 0.380 |
Why?
| | Anti-Allergic Agents | 1 | 2012 | 16 | 0.380 |
Why?
| | Mast Cells | 1 | 2012 | 55 | 0.370 |
Why?
| | Dermatitis, Atopic | 1 | 2012 | 39 | 0.370 |
Why?
| | Drug Resistance, Bacterial | 1 | 2012 | 81 | 0.370 |
Why?
| | Sleep | 1 | 2013 | 186 | 0.370 |
Why?
| | Adaptation, Psychological | 2 | 2008 | 229 | 0.310 |
Why?
| | Staphylococcal Infections | 1 | 2012 | 280 | 0.310 |
Why?
| | Staphylococcus aureus | 1 | 2012 | 331 | 0.300 |
Why?
| | Conditioning, Classical | 1 | 2007 | 33 | 0.280 |
Why?
| | Attention | 1 | 2008 | 159 | 0.270 |
Why?
| | Anti-Bacterial Agents | 1 | 2012 | 802 | 0.250 |
Why?
| | Psychomotor Performance | 3 | 2013 | 120 | 0.230 |
Why?
| | Ethanol | 1 | 2006 | 340 | 0.220 |
Why?
| | Reward | 2 | 2017 | 115 | 0.200 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2024 | 200 | 0.180 |
Why?
| | Cues | 2 | 2014 | 52 | 0.180 |
Why?
| | Students | 1 | 2023 | 228 | 0.170 |
Why?
| | Aging | 2 | 2016 | 706 | 0.160 |
Why?
| | Humans | 14 | 2024 | 52513 | 0.150 |
Why?
| | Male | 10 | 2019 | 26816 | 0.150 |
Why?
| | Clusterin | 1 | 2017 | 8 | 0.140 |
Why?
| | Food Supply | 1 | 2019 | 92 | 0.140 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2017 | 9 | 0.140 |
Why?
| | Child | 4 | 2019 | 7218 | 0.140 |
Why?
| | Food Hypersensitivity | 1 | 2019 | 100 | 0.140 |
Why?
| | Mesalamine | 1 | 2017 | 12 | 0.130 |
Why?
| | Health Literacy | 1 | 2019 | 132 | 0.130 |
Why?
| | Space Perception | 1 | 2016 | 10 | 0.130 |
Why?
| | Drug Hypersensitivity | 1 | 2017 | 39 | 0.130 |
Why?
| | Colitis, Ulcerative | 1 | 2017 | 66 | 0.130 |
Why?
| | Female | 9 | 2019 | 28219 | 0.130 |
Why?
| | Desensitization, Immunologic | 1 | 2017 | 107 | 0.120 |
Why?
| | Disaccharides | 1 | 2015 | 11 | 0.120 |
Why?
| | Urticaria | 1 | 2015 | 19 | 0.120 |
Why?
| | Meat | 1 | 2015 | 60 | 0.120 |
Why?
| | Syndrome | 1 | 2015 | 252 | 0.110 |
Why?
| | Lung | 1 | 2017 | 500 | 0.110 |
Why?
| | Forced Expiratory Volume | 1 | 2013 | 52 | 0.100 |
Why?
| | Discrimination Learning | 1 | 2013 | 57 | 0.100 |
Why?
| | Hospitals, University | 1 | 2012 | 75 | 0.090 |
Why?
| | Analysis of Variance | 2 | 2016 | 558 | 0.090 |
Why?
| | Language | 1 | 2013 | 138 | 0.090 |
Why?
| | Microbial Sensitivity Tests | 1 | 2012 | 286 | 0.090 |
Why?
| | Hospitals, Pediatric | 1 | 2012 | 243 | 0.090 |
Why?
| | Young Adult | 3 | 2016 | 4326 | 0.080 |
Why?
| | Adolescent | 3 | 2019 | 6725 | 0.070 |
Why?
| | Infant | 2 | 2019 | 3713 | 0.070 |
Why?
| | Child, Preschool | 2 | 2019 | 4056 | 0.070 |
Why?
| | Risk Factors | 2 | 2019 | 3951 | 0.070 |
Why?
| | Time Perception | 1 | 2007 | 28 | 0.070 |
Why?
| | Color Perception | 1 | 2007 | 11 | 0.070 |
Why?
| | Orientation | 1 | 2007 | 14 | 0.070 |
Why?
| | Environment | 1 | 2007 | 88 | 0.070 |
Why?
| | Animals, Newborn | 1 | 2006 | 366 | 0.060 |
Why?
| | Motor Activity | 1 | 2006 | 222 | 0.060 |
Why?
| | Feeding Behavior | 1 | 2006 | 192 | 0.060 |
Why?
| | Body Weight | 1 | 2006 | 523 | 0.060 |
Why?
| | Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 1 | 2024 | 1 | 0.060 |
Why?
| | HSP40 Heat-Shock Proteins | 1 | 2024 | 4 | 0.060 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2024 | 51 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 1 | 2006 | 1543 | 0.050 |
Why?
| | T-Lymphocytes | 1 | 2024 | 327 | 0.050 |
Why?
| | Treatment Outcome | 1 | 2012 | 5480 | 0.040 |
Why?
| | Rats | 1 | 2006 | 3181 | 0.040 |
Why?
| | Middle Aged | 4 | 2017 | 13081 | 0.040 |
Why?
| | Retrospective Studies | 1 | 2012 | 6661 | 0.040 |
Why?
| | Tertiary Healthcare | 1 | 2019 | 15 | 0.040 |
Why?
| | Respiratory Mucosa | 1 | 2017 | 10 | 0.040 |
Why?
| | Extracellular Space | 1 | 2017 | 36 | 0.040 |
Why?
| | DNA Mismatch Repair | 1 | 2017 | 18 | 0.040 |
Why?
| | Bleomycin | 1 | 2017 | 38 | 0.030 |
Why?
| | Aged | 3 | 2017 | 10181 | 0.030 |
Why?
| | Gene Knockdown Techniques | 1 | 2017 | 110 | 0.030 |
Why?
| | Cytoplasm | 1 | 2017 | 93 | 0.030 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2017 | 71 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2017 | 218 | 0.030 |
Why?
| | Fibrosis | 1 | 2017 | 197 | 0.030 |
Why?
| | Epithelial Cells | 1 | 2017 | 214 | 0.030 |
Why?
| | Random Allocation | 1 | 2016 | 285 | 0.030 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 123 | 0.030 |
Why?
| | Aspirin | 1 | 2017 | 123 | 0.030 |
Why?
| | Prevalence | 1 | 2019 | 1017 | 0.030 |
Why?
| | Immunoglobulin E | 1 | 2015 | 92 | 0.030 |
Why?
| | Cell Line | 1 | 2017 | 1030 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2017 | 910 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2017 | 1201 | 0.030 |
Why?
| | Swine | 1 | 2015 | 427 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2019 | 1682 | 0.030 |
Why?
| | Arkansas | 1 | 2019 | 2029 | 0.030 |
Why?
| | Quality of Life | 1 | 2019 | 881 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2017 | 1108 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2017 | 1481 | 0.020 |
Why?
| | Apoptosis | 1 | 2017 | 1120 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2017 | 1897 | 0.020 |
Why?
| | Adult | 2 | 2017 | 14148 | 0.020 |
Why?
| | Age Factors | 1 | 2012 | 1132 | 0.020 |
Why?
| | Mice | 1 | 2017 | 5943 | 0.020 |
Why?
|
|
Bell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|